Asian Pan-cancer Assay presented at FCS 2021

Recently, our lab developed test for molecular profiling of prevalent Asian cancers was presented at the Frontiers in Cancer Science 2021 conference!

This is a commercially available cancer tissue diagnostic platform created in collaboration by SingHealth, Agency for Science, Technology and Research (A*STAR)’s Diagnostics Development (DxD) Hub, Singapore General Hospital (SGH), National Cancer Centre Singapore (NCCS) and Lucence.

Check out our poster below.

---

Mr Cedric Ng

Chief Technology Officer, Cancer Discovery Hub

National Cancer Centre Singapore